New prophylactic therapy for patients with hemophilia A and B
A new study of patients with hemophilia A and B suggests that monthly prophylactic treatment with fitusiran reduces episodes of bleedings and improves health-related quality of life.
A new study of patients with hemophilia A and B suggests that monthly prophylactic treatment with fitusiran reduces episodes of bleedings and improves health-related quality of life.
